Faculty profile

Vishal Kukreti

Back to faculty

ProfessorDepartment of MedicineUniversity of Toronto

Vishal Kukreti

Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
9 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

298

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Improved survival and health care use with CAR-T vs historical care in relapsed/refractory large B-cell lymphoma.
Blood advances · 2026
Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma.
Leukemia & lymphoma · 2026
Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T.
Hematological oncology · 2026

All 25 publications

Latest funding

Canadian Cancer Rehabilitation (CanRehab) Team: Improving the systematic identification, management, and treatment of the adverse effects of cancer.
CIHR · 2019 · Co-investigator
$1,101,364
Decreasing Cancer Burden: Testing a Proactive Model of Care to Improve the Quality of Toxicity Management through Patient Activation for Cancer Self-Management during the Active Treatment Phase
CIHR · 2017 · Co-investigator
$961,492
A Web-Based Self-Management Support Program to Promote Adaptation to Cancer in the Acute Treatment Phase: Usability and Feasibility of the "I-Can Manage Cancer" Intervention
CIHR · 2016 · Co-investigator
$100,000

All 5 grants and awards

25 publications.

Improved survival and health care use with CAR-T vs historical care in relapsed/refractory large B-cell lymphoma.

Kordbacheh T, Chan KKW, Crump M, Ante Z, Liu N, Aminilari M, Gong IY, Bhella S, Vijenthira A, Kuruvilla J, Kridel R, Chen C, Kukreti V, Yang C, Hodgson D, Prica A, Rodin D

Blood advances20261 citationsOpen Access

DOI: 10.1182/bloodadvances.2025017401 PMID: 41544221

Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma.

Gong IY, Xiao NM, Chen C, Bhella S, Hueniken K, Marinoni M, Azab M, Aoki T, Kridel R, Kukreti V, Vijenthira A, Yang C, Rodin D, Jeeva M, Aminilari M, Malik N, Wells W, Hodgson D, Crump M, Prica A, Kuruvilla J

Leukemia & lymphoma2026

DOI: 10.1080/10428194.2026.2682290 PMID: 42295978

Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T.

Gong IY, Jeeva M, Hueniken K, Aminilari M, Marinoni M, Prica A, Rodin D, Bhella S, Aoki T, Azab M, Chen C, Kridel R, Kukreti V, Vijenthira A, Yang C, Malik N, Wells W, Metser U, Crump M, Hodgson D, Kuruvilla J

Hematological oncology2026

DOI: 10.1002/hon.70183 PMID: 41774783

Survivorship care for patients curatively treated for Hodgkin's and non-Hodgkin's lymphoma: a scoping review.

Powis M, Hack S, Fazelzad R, Hodgson D, Kukreti V

Journal of cancer survivorship : research and practice20252 citationsSenior author

DOI: 10.1007/s11764-023-01500-3 PMID: 38048010

Outcomes of Primary Mediastinal B-cell Lymphoma Patients with Partial Metabolic Response: A Multicenter Retrospective Analysis.

Wattakiyanon N, Aminilari M, Ye XY, Metser U, Prica A, Crump M, Kuruvilla J, Kukreti V, Kridel R, Vijenthira A, Bhella S, Cheung M, Vivekanandan T, Rodin D, Tsao M, Hodgson D

Advances in radiation oncology20251 citationsOpen Access

DOI: 10.1016/j.adro.2025.101744 PMID: 40291511

A Web-Based Cancer Self-Management Program (I-Can Manage) Targeting Treatment Toxicities and Health Behaviors: Human-Centered Co-design Approach and Cognitive Think-Aloud Usability Testing

Howell D, Lukosius DB, Avery J, Santaguida A, Powis M, Papadakos T, Addario V, Lovas M, Kukreti V, Haase K

JMIR Cancer202314 citationsOpen Access

DOI: 10.2196/44914

Impact of a Training Program on Oncology Nurses’ Confidence in the Provision of Self-Management Support and 5As Behavioral Counseling Skills

Howell D, McGowan P, Bryant-Lukosius D, Kirkby R, Powis M, Sherifali D, Kukreti V, Rask S, Krzyzanowska MK

Cancers20239 citationsOpen Access

DOI: 10.3390/cancers15061811 PMID: W4327741199

Implementation and Impact of Choosing Wisely Recommendations in Oncology

Sonieya Nagarajah, Melanie Powis, Rouhi Fazelzad, Monika Karolina Krzyzanowska, Vishal Kukreti

JCO Oncology Practice202216 citationsSenior author

DOI: 10.1200/op.22.00130 PMID: 35930757

Clinical utility of interim CT scans in patients receiving chemoimmuntherapy for first line treatment of follicular lymphoma.

Manji F, Bhella S, Kridel R, Kukreti V, Kuruvilla J, Prica A, Crump M

Leukemia & lymphoma20221 citations

DOI: 10.1080/10428194.2022.2123226 PMID: 36166635

A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.

Monteith BE, Venner CP, Cheung MC, Pater J, Shepherd L, Richardson H, Reece D, Gul E, Lalancette M, Castonguay V, Kukreti V, Tiedemann R, Phua C, Bhella S, Dudebout J, Sherry M, Yen H, Chen BE, Hay AE

European journal of haematology20211 citations

DOI: 10.1111/ejh.13671 PMID: 34053112

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Vishal Kukreti

Research

Latest papers

Latest funding

Improved survival and health care use with CAR-T vs historical care in relapsed/refractory large B-cell lymphoma.

Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma.

Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T.

Survivorship care for patients curatively treated for Hodgkin's and non-Hodgkin's lymphoma: a scoping review.

Outcomes of Primary Mediastinal B-cell Lymphoma Patients with Partial Metabolic Response: A Multicenter Retrospective Analysis.

A Web-Based Cancer Self-Management Program (I-Can Manage) Targeting Treatment Toxicities and Health Behaviors: Human-Centered Co-design Approach and Cognitive Think-Aloud Usability Testing

Impact of a Training Program on Oncology Nurses’ Confidence in the Provision of Self-Management Support and 5As Behavioral Counseling Skills

Implementation and Impact of Choosing Wisely Recommendations in Oncology

Clinical utility of interim CT scans in patients receiving chemoimmuntherapy for first line treatment of follicular lymphoma.

A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.

Canadian Cancer Rehabilitation (CanRehab) Team: Improving the systematic identification, management, and treatment of the adverse effects of cancer.

Decreasing Cancer Burden: Testing a Proactive Model of Care to Improve the Quality of Toxicity Management through Patient Activation for Cancer Self-Management during the Active Treatment Phase

A Web-Based Self-Management Support Program to Promote Adaptation to Cancer in the Acute Treatment Phase: Usability and Feasibility of the "I-Can Manage Cancer" Intervention

Decreasing Cancer Burden: Testing a Proactive Model of Care to Improve the Quality of Toxicity Management through Patient Activation for Cancer Self-Management during the Active Treatment Phase

Towards successful migration to computerized physician order entry for chemotherapy

Frequent collaborators

Michael Crump

Anca Prica

John Kuruvilla

Christine Chen

Monika Krzyzanowska

Robert Kridel

David Hodgson

Sita Bhella

Melanie Powis

Abi Vijenthira

Doris Howell

Danielle Rodin

Chloe Yang

Donna Reece

Matthew Cheung

Lisa Hicks

Inna Gong

Nauman Malik

Woodrow Wells

Denise Bryant-Lukosius

Geoffrey Liu

Rodger Tiedemann

May Tsao

Farheen Manji

Asad Merchant

Patrick Gullane

Patrik Rogalla

Ur Metser

Richard Tsang